Lv11
50 积分 2025-09-29 加入
EP.12.55 Aumolertinib Combined With Metronomic Oral Vinorelbine in Advanced EGFR-Mutant NSCLC
13分钟前
求助中
Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer
6天前
已完结
Effect of tumor burden on survival in patients with stage IV EGFR-mutant NSCLC receiving osimertinib monotherapy
8天前
已关闭
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
9天前
已完结
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study
10天前
已完结
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer
11天前
已完结
Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma
14天前
已完结
Trends in Stage I Lung Cancer
15天前
已完结
Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer
17天前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
17天前
已完结
皖公网安备34019202002308
